8 December 2021

The Center of Molecular and Biomolecular Informatics (CMBI) is leading research on bridging artificial intelligence (AI) and 3D modelling of protein structures. Recently, on 3 December 2021, Li Xue et al., theme Cancer development and immune defence, published DeepRank, a deep learning framework for data mining 3D protein-protein structures, in Nature Communications and GitHub. DeepRank makes deep learning (DL) accessible for broad biochemists and life scientists.

What can it be used for? 

DeepRank provides an easy DL platform; researchers come up with their own research questions related with 3D protein structures. DeepRank takes 3D protein-protein structures as input, and outputs a prediction. The output of DeepRank is defined based on the users’ research question and their training data. For example, how two proteins interact with each other in 3D space and where do they interact (i.e., which part of a protein interacts with which part of another protein)? Whether a mutation is disease-causing or not? Is the protein-protein interaction that we observe in X-ray experiments a biological interaction or crystal artefacts? And many many more.

 

Image: illustration of DeepRank 

Protein functions are encoded in their 3D shapes. In the past decades, a number of imaging techniques were developed (e.g., X-ray, NMR, Cryo-EM) and a large number of experimentally determined 3D protein structures have been accumulated. A human expert trained for 30+ years could excruciatingly examine them by eyes as the spatial arrangement of atom pairs and interactions shed light on the secrets of biological life. However, human inspection is not efficient. And the relationship between 3D structures of diverse proteins and their functions is too intricate to be even mastered by human experts.

Using quantitative statistical approach to approximate/simulate human perception was visioned and pioneered by Frank Rosenblatt, a psychologist, in 1958. After a half-century, this dream finally came true recently when deep learning achieved human-level accuracy in 2D image perceptions. However, such breakthroughs did not naturally translate to molecular biology.

DeepRank aims to facilitate such translations. Removing daunting phases of data preprocessing on millions of structures, DeepRank allows a user to easily train a 3D-CNN to scan protein structures for desired patterns and make predictions. In the paper, they showcase the effectiveness of DeepRank on two distinct applications in structural biology.

Image: Xue's lab logo showing their research theme: AI-boosted 3D modeling

Potential applications are wide. Xue’s lab is using DeepRank to aid cancer vaccine design. CMBI is extending DeepRank to predict pathogenicity of human genetic variants. Together with Utrecht University, DeepRank is further leveled up with Graph Neural Networks, a trending DL technique that can be used for protein interaction networks and so on.

We envision DeepRank to stimulate community efforts of exploiting deep learning to tackle long-standing challenges in life science.

This work is a result of collaborations with the Netherlands eScience Center and Utrecht University

read more

Related news items


What does the shingles vaccine teach us about other vaccines? Investigating the role of trained immunity

27 January 2022

The vaccine for shingles, a condition that causes itching, pain, and blisters, is 90% effective, even in elderly. This is remarkable, since most vaccines offer less protection in elderly. Radboudumc is investigating why this vaccine works so well and how it might help us to develop better vaccines.

read more

RIMLS PhD retreat 2022 Register now

25 January 2022

This year, the 2-day RIMLS PhD retreat will be held on 14 & 15 July 2022 in the Koningshof, Veldhoven. We are aiming for a live event again!

read more

Most COVID-19 ICU survivors experience symptoms one year after ICU admission Publication in JAMA

25 January 2022

75% of the COVID-19 survivors who were treated in the Intensive Care Unit (ICU) experience physical, mental and/or cognitive problems one-year post ICU. This shows the large-scale MONITOR-IC study led by Radboudumc.

read more

Laurens Verscheijden awarded doctorate degree 'cum laude'

19 January 2022

Laurens Verscheijden of the Department of Pharmacology and Toxicology, defended his PhD thesis, entitled "Mechanistic models for the prediction of brain drug exposure and response in the paediatric population: A virtual child reaching maturation.

read more

Aerobe exercise has a positive effect on brain function in Parkinson's disease patients

18 January 2022

Radboudumc researchers have shown that the brain function of patients with Parkinson's disease improved with regular exercise, which seems to strengthen the connections between different brain areas, while inhibiting brain shrinkage.

read more